VIC Tech Continues to Grow Its Medical Advisory Board

VIC Tech is pleased to announce the addition of four new members to its Medical Advisory Board to help guide VIC with additional domain expertise across a variety of life science disciplines. MAB members support VIC’s...

Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio

We live in eventful times. The world is changing at a dizzying pace…inflation, war and geopolitical instability, climate change, the pandemic, and supply chain issues are just a few of the important change factors. And...

VIC Fellows Spotlight: Alexandra Antonioli, MD, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...

CardioWise, Inc. Selected for the Inaugural Edison Accelerator By GE Healthcare in Collaboration with Nex Cubed

CardioWise Demonstrates innovative, Scalable Solutions for Cardiac Diagnosis Fayetteville, AR - Six digital healthcare start-ups from five countries have officially become the first cohort of the Edison Accelerator in...

VIC 2022 Mid-Year Update Executive Summary

The first half of the year has been exciting for VIC and our portfolio companies, including new pre-clinical and clinical milestones reached, products released to market, recent funding, and more Click Here to download...

Inside CTTC at Vanderbilt University with Assistant Director, Physical Sciences Ashok Choudhury

Tell us about your background in technology transfer and commercialization. What experiences led you to this role? During my role as a researcher at a national laboratory, I worked at a DOE “User Center” where I had the...

VIC Tech Announces New Class of Fellows

The VIC Tech investment model is unique; it sources promising life science innovation directly from universities across the nation, allocating funding to form startup companies and advance these technologies to exit via...

Cellia Science Announces Dr. Wilbur Lam as Chief Medical Officer

Dr. Lam brings clinical and technical expertise to hematology analyzer development at Cellia Science Fayetteville, AR - Cellia Science, Inc., announced today the appointment of Wilbur Lam, MD, PhD, as Chief Medical...

CardioWise Joins the Lucem Health Innovation Collaborative as a Founding Member

Bringing AI/ML to the Front Lines of Healthcare Fayetteville, AR - CardioWise® and Lucem Health™ announced that CardioWise has become a founding member of the Lucem Health Innovation Collaborative, a partner program...

Part 1: Challenges and Solutions for University Technology Commercialization

The honest truth? Deciding which early-stage technologies will be successful is really hard. This is even more the case when you add the challenges faced in a university setting. Although I’m currently on the investment...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Nob Hill Therapeutics Secures Series A Funding to Advance Breakthrough Respiratory Technologies
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Zebra Analytix